The Role of the European Commission

Similar documents
TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

Work plan for GMP/GDP Inspectors Working Group for 2016

Section 1: Development of the EU s competence in the field of police and judicial cooperation in criminal matters

2012 IAS CONFERENCE. Case Study N 2: Monitoring EU LAW Implementation. Pascal Hallez René Scholzen 12 October 2012

NEGOTIATING FRAMEWORK FOR TURKEY. Principles governing the negotiations

The European regulatory system for medicines and the European Medicines Agency

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Ordinary Legislative Procedure

Competentes en Medicamentos

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Council of the European Union Brussels, 14 November 2014 (OR. en) Ensuring respect for the rule of law in the European Union

Agence fédérale des médicaments et des produits de santé

THE WESTERN BALKANS LEGAL BASIS OBJECTIVES BACKGROUND INSTRUMENTS

European Health Insurance Card

Under European law teleradiology is both a health service and an information society service.

UK Implementation of Directive 2011/24/EU on patients rights in cross-border healthcare. Rob Dickman International Division

Clinical Trial Data Transparency Environment & Expectations EMA Policy - Clinical Trials Regulation

SUMMARY OF THE IMPACT ASSESSMENT

The Århus Convention by Jens Hamer, ERA

COMMISSION OF THE EUROPEAN COMMUNITIES. COMMISSION REGULATION (EC) No /..

2. Europol's cooperation agreements with third countries and international organisations (Art. 31);

The joint EU Telematics governance model

European Council Brussels, 2 February 2016 (OR. en)

Regulatory approval routes in the European System for Medicinal Products

Implementing & Delegated Acts

COMMISSION DECISION. of establishing the REFIT Platform

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1

Statewatch analysis. EU Reform Treaty Analysis no. 3.1: Revised text of Part One of the Treaty establishing the European Community (TEC)

AD 13/15 CONF-RS 2/15 1

Legal protection of children from sexual exploitation: The Lanzarote Convention and the ONE in FIVE campaign

A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

Third EU Health Programme

A European Medicines Verification System

QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September /09 LIMITE PI 93

THE PRINCIPLE OF SUBSIDIARITY

Speech for Minister Reilly. Presentation to the ENVI Committee of the European Parliament. 23rd January Ireland s Presidency : Health Priorities

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

Minister Shatter presents Presidency priorities in the JHA area to European Parliament

List of actions by the Commission to. advance. LGBTI equality #EU4LGBTI. Justice and Consumers

Political Aspects of the Mandate of the European Bank for Reconstruction and Development

The EU Democratic Governance Pact

How To Understand The Paediatric Regulation

Biotech Concerto #3. European Clinical Trial Environment

Compilation of Community Procedures on Inspections and Exchange of Information

Taxing Multinationals: Recent developments in the EU

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION ON MONITORING THE APPLICATION OF COMMUNITY LAW (2003) OVERALL POSITION

Brief Summary on the Philippine B bilateral Air Services Agreement

HSE: Frequently Asked Questions

The EU Clinical Trial Regulation A regulator s perspective

EUROPEAN PARLIAMENT AND COUNCIL DIRECTIVE. on a common framework for electronic signatures

Setting the legal context for telemedicine in the EU

20-21 May 2015, Lisbon, Portugal. Highlights. Speakers:

Fit for the European Rail Market Training Competence - Certification

ROADMAP. A. Context and problem definition

EDQM Certificates of Suitability: Cooperation Among Inspectorates in Europe And Beyond

Clinical trials regulation

EUROPEAN COMMISSION SERVICE SPECIFIC PRIVACY STATEMENT (SSPS) 1. Online services on the Participant Portal

A European perspective on creating standards and assuring compliance

COMMISSION DECISION C(2013)343. of 22 January 2013

THE EUROPEAN CONVENTION THE SECRETARIAT. Brussels, 26 May 2003 (OR. fr) CONV 724/03 VOLUME 1. COVER NOTE from : Praesidium

DATE: 1 APRIL Introduction

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Council of the European Union Brussels, 26 June 2015 (OR. en)

Response of the Northern Ireland Human Rights Commission on the Health and Social Care (Control of Data Processing) NIA Bill 52/11-16

PRINCIPLES OF EU ENVIRONMENTAL LAW

White Paper The EU Clinical Trials Regulation Main Changes and Challenges

COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT AND THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

RECOMMENDATIONS COMMISSION

PRIORITIES TURKEY MAY 2013

How To Understand The Rules Of The European Union

1. Name of pharmacopoeia

Version 56 (29/11/2011)

Compilation of Community Procedures on Inspections and Exchange of Information

Review of the Balance of Competences between the United Kingdom and the European Union Civil Judicial Cooperation

Guideline on good pharmacovigilance practices (GVP)

Amount. 2. Pie Chart and Table sorted by Institutions (Council's Position): TOPIC 1: Annual Budget Introduction

Standard Summary Project Fiche IPA centralised programmes

Council of the European Union Brussels, 5 March 2015 (OR. en)

Informal Meeting of EU Ministers Responsible for Territorial Cohesion and Urban Matters. Declaration of Ministers towards the EU Urban Agenda

The EC Joint Research Centre on Aviation Security

Presentation by Mr. Richard Bruton, Minister of Jobs, Enterprise and Innovation to the IMCO Committee of the European Parliament, Brussels

COUNCIL OF THE EUROPEAN UNION. Brussels, 4 May /12 Interinstitutional File: 2008/0090 (COD) LIMITE INF 75 API 56 JUR 253 CODEC 1153

COMMISSION STAFF WORKING DOCUMENT. Executive Summary of the Impact Assessment. Accompanying the document

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

SUMMARY OF THE IMPACT ASSESSMENT

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION RECOMMENDATION. of

COMMITTEE ON STANDARDS AND TECHNICAL REGULATIONS (98/34 COMMITTEE)

How To Regulate Data Protection In European Union

Questions & answers on signal management

European judicial training Justice

Executive Summary. Public Health and the EU: an overview

Review of the Balance of Competences between the United Kingdom and the European Union Health

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP)

Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from

Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products

Transcription:

Instrument for Pre-Accession Programme IPA European Medicines Agency London, 01 February 2010 The Role of the European Commission Sabine Atzor sabine.atzor@ec.europa.eu Topics 1. European Union Competence 2. Roles and Responsibilities of European Bodies 3. Role of the European Commission in Pharmaceuticals 1

EU Competence - TFEU 1. Exclusive competence (Art. 3) Only EU to legislate and adopt legally binding acts Customs union Common commercial policy Conclusion of international agreements 2. Shared competence with MS (Art. 4) EU and MS to legislate and adopt legally binding acts Internal market Common safety concerns in public health matters 3. Actions to support, coordinate actions of the MS (Art. 6) Protection and improvement of human health There is a difference European Union since 1957 27 Member States Mandate: Common market Harmonised legislation Intergovernmental cooperation Trade Agreements: 3rd countries Relevant Institutions/ Bodies: European Council European Commission Council European Parliament European Court of Justice --- EMA (European Medicines Agency) ECDC (European Center for Disease Prevention and Control) Council of Europe since 1949 47 Member Countries Mandate: Human rights (European Human Right Convention) Rule of law (criminal & civil) Pluralist democracy Relevant Bodies: Committee of Ministers Parliamentary Assembly European Court of Human Rights DG I: Human Rights & Legal DG III: Social Cohesion --- EDQM: European Directorate for the Quality of Medicines & Healthcare 2

European Bodies European Council (Heads of States & gov.) European Commission Council (Member States) European Parliament European Court of Justice Committee of the Regions Economic and Social Committee Agencies (e.g. EMA, ECDC, ECHA) European Commission Directorates General, e.g.* DG Health and Consumer Policy (SANCO) Health Programmes Safety of food, blood Pharmaceutical legislation DG Enterprise and Industry (ENTR) Competitiveness & Biotechnology in the Pharmaceutical Industry DG Research (RTD) 7th Framework Programme Innovations Medicines Initiative (IMI) DG Development (DEV) Health related programmes with developing countries DG Enlargement (ELARG) DG Trade (TRADE) Leads negotiation on third country agreements *List of services and tasks not exhaustive! 3

EU Competence Treaty on the Functioning of the European Union - TFEU 1. Approximation of laws (Art. 114 ex Art. 95) Free movement of goods 2. Public Health (Art. 168 - ex Art. 152) Programmes to improve public health Intergovernmental cooperaton Combating serious cross-border health threats High standards of quality and safety for medicinal products and medical devices Organs & substances of human origin, blood, blood derivatives EU Regulatory Framework relevant for Pharmaceuticals Harmonised Legislation Clinical Trials Marketing Manufacture Import Wholesale Distribution Blood & Tissue Products Inspections MS implement legislation into national laws Non harmonised legislation (but subject to Treaty) Pharmacies (incl. Internet) Retailers (incl. Internet) Health Care Professionals Health Insurances, Reimbursement MS establish national legislation on basis of regional experiences/ systems 4

Regulation (general) Legal Acts (Art. 288 TFEU, ex Art. 249) directly binding directly applicable in all MS Directive (general) Decision (specific) Recommendations and opinions binding framework adressed to MS for implementation in national legislation directly binding upon those adressed no binding force Legal Acts Examples - Pharmaceuticals Regulation Directive Decision Specific guidelines 726/2004 Centralised authorisation procedure and EMA 2001/83(2)/EC, amended by 2004/27(8)/EC Human (veterinary) medicinal products all marketing authorisations under the centralised procedure Guidance to industry on interpretation & administrative practice 5

Main Role of the Commission (1) to make proposals for harmonised legislation (Art. 17 TEU, Art. 115 TFEU - ex Art. 94 ) e.g. Pharmaceutical package incl. legal proposals on Pharmacovigilance Falsified medicines Information to patients to coordinate intergovernmental cooperation (Art. 168 TFEU ex Art. 152). e.g. Influenza Pandemic Health Security Committee Commission Staff Working Documents: Vaccination strategies Purchase Agreements Main Role of the Commission (2) to issue recommendations to the Council for international treaties and conduct negotiations (Art. 218 TFEU ex Art. 300) e.g. Mutual Recognition Agreements Agreements for Conformity Assessment (ACAA) Preparation for accession of new Member States Assess applicants ability to meet conditions for membership Funds and operates Pre-Accession Programmes to ensure that provisions of the Treaty are applied (Art. 258 TFEU ex Art. 226, Art. 263- ex Art. 230) guardian of the Treaty e.g. transposition & application of EU legislation by MS Initiative for infringement procedures 6

Co-decision procedure Role of the Commission Art. 294 TFEU (ex Art.251) Principle: 2 readings by Parliament & Council 1. submits legal proposal based on Consultation of stakeholders Assessment of social, economic, environmental impacts Consultation of all Commission Services Adoption by College of Commissioners 2. participates in Council negotiations 3. gives a position on common position and changes from European Parliament 4. If COM has a negative opinion on changes, Council shall act unanimously Delegated Acts Implementing Acts 1) Delegated Acts (Art. 290 TFEU) Powers enferred to the COM to adopt non-legislative acts To amend certain non-essential elements of legislation Commission seeks assistance by MS experts Council and EP may decide to revoke delegation 2) Implementing Acts (Art. 291 TFEU) Uniform conditions for implementing legally binding acts Conclusion: delegated and implementing acts replace former comitology procedure 7

European Parliament.. Representation of the EU citizens Discuss and vote on legal proposals Specific committees (e.g. ENVI) Raise questions to the European Commission Initiate debates on certain topics e.g. on counterfeit medicines in 2007 Adopt resolutions, declarations e.g. resolution on counterfeit medicines e.g. declaration on active substances Council Representation of EU Member States Involvement in legislative process (Co-decision) Committee 207 (Ex 133): assists Commission in conducting negotiations with third countries or international organisations (Examples: MRA, ACAA) 8

European Court of Justice.. Interpretation of Union legislation Infringements of Union legislation Establishes Case law Examples: Parallel trade with pharmaceuticals Doc Morris Case Cases on pharmacies.. Involvement of Member States 1. Governments Consultation Committees Pharmaceutical Committee Veterinary Pharmaceutical Committee 2. National Agencies Heads of (Veterinary) Medicinal Agencies and working groups 3. Technical Experts Future - tbd Involvement of MS experts in preparation of delegated and implementing acts by COM Committees and Working groups at EMA, e.g. CHMP, CVMP Specific Working Groups and Working Parties 9

Involvement of Stakeholders 1. Consultations via websites COM http://ec.europa.eu/enterprise/sectors/pharmaceuticals/index_en.htm EMA / http://www.ema.europa.eu 2. Stakeholder/ Interested Parties Meetings 10